Olanzapine vs risperidone costs among US Medicaid beneficiaries

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1396, 2003-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olanzapine versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs among Texas Medicaid Recipients

By Rascati K.L.

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 683-697

Adis International

Access to resources Recommend Favorite

OOP costs high among Medicare beneficiaries with cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 670, 2013-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Challenges in Merging Medicaid and Medicare Databases to Obtain Healthcare Costs for Dual-Eligible Beneficiaries: Using Diabetes as an Example

By Prela Cecilia M.

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 167-177

Adis International

Access to resources Recommend Favorite

Olanzapine and risperidone on a par in schizophrenia

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Olanzapine and risperidone on a par in schizophrenia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite